Pharmaceutics International, Inc.
Drug product CDMO built for complexity—from potent compounds to commercial scale.
Listed on cdmo.directory
Drug product CDMO specializing in aseptic injectables, oral solid dose, lyophilization, and prefilled syringes with 30+ years of experience in complex formulations and potent compounds; now part of Jabil. Headquartered in Hunt Valley, United States.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Synthetic chemistry infrastructure
- Capabilities
- HPAPIDEA licensed
Fill-finish formats
Regulatory clearances
Services
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Formulation Development
- Technology Transfer
- Prefilled Syringe (PFS) Filling
- Vial Filling
- Lyophilization (Freeze Drying)
- Sterile Fill-Finish & Aseptic Manufacturing
- Oral Solid Dosage Manufacturing
- HPAPI Manufacturing (High-Potency)
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Process Development
- Controlled Substance Manufacturing
About this organization
Overview
Pharmaceutics International, Inc. (Pii) is a contract development and manufacturing organization (CDMO) specializing in drug product development and manufacturing across early-stage, clinical, and commercial volumes. Acquired by Jabil Inc. on February 3, 2025, Pii combines 30+ years of pharmaceutical manufacturing expertise with Jabil's industry-leading automation and manufacturing capabilities.
Core Capabilities
Formulation & Development Services
- Formulation development focused on bioavailability, stability, and adherence
- Contract analytical services for fast, reliable testing and quality compliance
- Solid-state characterization and complex formulation problem-solving
Manufacturing Services
- Aseptic/Injectables: Sterile fill-finish manufacturing for injectable drug products
- Oral Solid Dose: Custom solutions for tablets, soft gels, and liquid oral formulations
- Lyophilization: Freeze-drying capabilities for injectable products
- Prefilled Syringes: Recent $3.6M investment (November 2024) in advanced labeling, fill/finish, and automated visual inspection technologies
- Controlled Substances: DEA-compliant manufacturing and storage for potent and controlled-substance drugs
Secondary Services
- Packaging, labeling, serialization, and kitting
- Quality assurance and regulatory compliance support
- Technology transfer and scale-up from pilot to commercial production
Facilities & Infrastructure
Four dedicated manufacturing and support facilities in Hunt Valley, Maryland:
- Beaver Court (80,000 sq ft): Aseptic manufacturing and oral solid dose production with DEA vaults
- Gilroy Road (72,000 sq ft): Oral research, development, and manufacturing with DEA vaults
- Beaver Dam (52,500 sq ft): Analytical and quality control laboratories
- Golden West (72,500 sq ft): Labeling, serialization, and kitting operations
Quality & Regulatory
- 100% FDA license to operate
- 300+ scientists and support staff
- 5 drug product approvals in 2023
- 90% of clients report effective solutions delivery
- Emphasis on quality assurance, compliance, and transparency
Certifications
Locations
Beaver Court
Hunt Valley · Maryland · United States
Gilroy Road
Hunt Valley · Maryland · United States
Beaver Dam
Hunt Valley · Maryland · United States
Golden West
Hunt Valley · Maryland · United States
Beaver Court (Aseptic & Oral Dose)
Hunt Valley · Maryland · United States
Gilroy Road (Oral Development & Manufacturing)
Hunt Valley · Maryland · United States
Beaver Dam (Analytical & QC Labs)
Hunt Valley · Maryland · United States
Golden West (Labeling & Serialization)
Hunt Valley · Maryland · United States
Submit a verified review for this organization.
Markdown mirror: /companies/pharm-int.md